{'fraction_non_alphanumeric': 0.022292993630573247, 'fraction_numerical': 0.030254777070063694, 'mean_word_length': 5.106796116504855, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Risk of lymphoma in patients with inflammatory bowel disease.

JDL Lymphoma is one of the 10 most common cancers in the United States, but the likelihood of any particular individual being diagnosed with lymphoma is still relatively low. The incidence of lymphoma in the general population ranges from approximately 15 cases per 100,000 people per year to 100 cases per 100,000 people per year, depending on the patient’s age. In the absence of immunosuppressive therapies, patients with inflammatory bowel disease (IBD) probably have, at most, only a very slightly increased risk of lymphoma compared to the general population.